PUBLISHER: The Business Research Company | PRODUCT CODE: 1426348
PUBLISHER: The Business Research Company | PRODUCT CODE: 1426348
A Clinical Trial Management System (CTMS) serves as a software platform specifically designed to streamline and enhance the management of clinical trials. This comprehensive solution is geared towards centralizing, organizing, and automating various facets of the clinical trial process, thereby facilitating efficient study planning, execution, monitoring, and reporting.
Two primary categories of Clinical Trial Management Systems are enterprise-based and site-based. An enterprise-based CTMS is a software solution implemented and utilized across an entire organization or enterprise. It serves as a centralized platform for managing all clinical trials conducted by the organization. The key components of a CTMS encompass software, services, and hardware, which are delivered through cloud-based, web-based, and on-premises modes. These solutions cater to the needs of pharmaceutical and biopharmaceutical companies, medical device manufacturers, clinical research organizations (CROs), and various other end-users involved in the clinical trial ecosystem.
The clinical trials management system (CTMS) research report is one of a series of new reports from The Business Research Company that provides clinical trials management system (CTMS) market statistics, including the clinical trials management system (CTMS)'s global market size, regional shares, competitors with a clinical trials management system (CTMS) market share, detailed clinical trials management system (CTMS) market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trials management system (CTMS). This clinical trials management system (CTMS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical trial management system (ctms) market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth observed during the historical period can be attributed to several key factors, including the escalating complexity of clinical trials, a rise in the number of global clinical trials, adherence to stringent regulatory compliance requirements, a heightened emphasis on patient-centric trials, and the growing trend of outsourcing clinical trials. These factors collectively contributed to the expansion witnessed in the past.
The clinical trial management system (ctms) market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The anticipated growth in the forecast period can be attributed to several key drivers, including a heightened emphasis on real-time data access, increased integration with Electronic Health Records (EHRs), a rise in virtual and decentralized trials, a focus on risk-based monitoring, and advancements in analytics and artificial intelligence (AI). Noteworthy trends expected in the forecast period include a strong focus on regulatory compliance and data security, the emergence of adaptive clinical trial designs, the development of collaborative platforms for stakeholder engagement, the implementation of remote site monitoring and management, and ongoing efforts to evolve data standards and improve interoperability. These trends collectively contribute to the projected growth in the coming period.
The expansion of decentralized clinical trials (DCTs) is anticipated to be a significant driver in propelling the growth of the clinical trial management system (CTMS) market moving forward. Decentralized clinical trials utilize telemedicine and local healthcare services, minimizing or eliminating the need for patients to visit traditional hospital-based trial locations. CTMS plays a crucial role in overseeing these trials by monitoring participant activities, recruitment, and providing comprehensive oversight and reporting. Notably, as per a report by Clinical Trials Arena in December 2021, the projected number of trials incorporating decentralized and virtual components is expected to soar to about 1,300 trials in 2022, marking a substantial 28% surge from the 1,000 trials recorded in 2021. Hence, the upward trend in decentralized clinical trials is poised to significantly fuel the growth of the clinical trial management system (CTMS) market.
The burgeoning demand for personalized medicine stands as another key factor propelling the trajectory of the clinical trial management system (CTMS) market. Personalized medicine involves leveraging an individual's genetic profile to tailor decisions regarding disease prevention, diagnosis, and treatment. CTMS plays a pivotal role in customizing the clinical trial process by adapting recruitment strategies, protocol designs, data collection methods, patient engagement approaches, and data analysis to suit the specific needs of each patient. Notably, as highlighted in the Scope and Significance of Progress in 2022 report by the Personalized Medicine Coalition, the Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, accounting for approximately 34% of all newly approved therapeutic molecular entities. This surge in demand for personalized medicine significantly contributes to the expansion of the clinical trial management system (CTMS) market.
Concerns regarding data security have significantly contributed to the sluggish growth observed in the clinical trial management system (CTMS) market. These concerns encapsulate the risks and potential threats associated with safeguarding organizational data against unauthorized access, usage, disclosure, disruption, alteration, or destruction of digital assets. In the realm of CTMS, data security apprehensions act as a limiting factor by impeding the adoption of CTMS solutions, elevating associated costs, necessitating compliance with stringent regulations, and heightening susceptibility to cybersecurity threats. A pertinent example highlighting the impact of such concerns is the data breach encountered by the University of California, San Francisco (UCSF) in 2021, wherein personal information belonging to around 1,600 participants in a clinical trial was compromised. Consequently, these data security apprehensions significantly impede the expansion of the clinical trial management system (CTMS) market.
Key industry players in the clinical trial management system (CTMS) arena are driving innovation by introducing new technological platforms, particularly Software as a Service (SaaS) solutions integrated with artificial intelligence, to expedite drug development processes. SaaS-based CTMS represents a cloud-hosted software platform specifically designed to efficiently manage and oversee various facets of clinical trials. This approach enables accessibility from any location with an internet connection, diminishing the necessity for local software installations and streamlining maintenance efforts. For instance, in June 2023, Saama Technologies, Inc., a prominent US-based provider of clinical development software and services, unveiled a unified platform comprising SaaS-based products complementing their existing artificial intelligence and machine learning-based solutions. This innovative platform streamlines clinical development and commercialization processes by automating critical CTMS functions, slashing query generation times by up to 90%, and significantly reducing study data transformation and analysis durations. It provides a consolidated interface offering comprehensive insights into trial operations and patient progress, consolidating essential information into a singular, easily accessible location.
In March 2021, Advarra Inc., a prominent US-based entity specializing in clinical research, successfully acquired Bio-Optronics for an undisclosed sum. This strategic acquisition represents a significant enhancement to Advarra's existing capabilities by integrating Bio-Optronics' strengths into its portfolio. By joining forces, Advarra aims to bolster its offerings, delivering comprehensive solutions tailored for research institutions, sponsors, and contract research organizations. This integration is geared towards optimizing and streamlining the entire clinical research process, catering to the evolving needs and demands of the industry stakeholders. Bio-Optronics, a renowned US-based company focused on healthcare software and services.
Major companies operating in the clinical trial management system (ctms) market report are The International Business Machines Corporation, Oracle Corporation, Laboratory Corporation of America Holdings, IQVIA Holdings Inc., Wipro Limited, ICON Public Limited Company, PAREXEL International Corporation, Veeva Systems Inc., Bioclinica Inc., Medidata Solutions Inc., Calyx.ai, Clario Medical Imaging Inc., Advarra Inc., Bio-Optronics Inc., MasterControl Inc., ERT Clinical, iWeb Technologies Limited, Anju Software Inc., Axiom Real-Time Metrics, EClinForce Inc., MedNet Solutions Inc., DSG Inc., ArisGlobal LLC, DZS Clinical Services Inc., Datatrak International Inc., Nextrials Nc., SimpleTrials, PHARMASEAL International Limited, Crucial Data Solutions Inc., RealTime Software Solutions LLC
North America was the largest region in the clinical trial management system (CTMS) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial management system (ctms) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the clinical trial management system (ctms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The clinical trial management system (CTMS) market includes revenues earned by entities by providing services such as study planning and design, site selection and management, patient recruitment and enrollment, clinical data management, and monitoring and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial management system (CTMS) market also includes sales of clinical trial analytics tools and mobile applications that are used in providing clinical trial management services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Trial Management System (CTMS) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical trial management system (CTMS) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clinical trial management system (CTMS)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial management system (CTMS) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.